Literature DB >> 17996026

Molecular interaction in the mouse PAG between NMDA and opioid receptors in morphine-induced acute thermal nociception.

Carla Ghelardini1, Nicoletta Galeotti, Elisa Vivoli, Monica Norcini, Wei Zhu, George B Stefano, Massimo Guarna, Enrica Bianchi.   

Abstract

Previous evidence demonstrates that low dose morphine systemic administration induces acute thermal hyperalgesia in normal mice through microOR stimulation of the inositol signaling pathway. We investigated the site of action of morphine and the mechanism of action of microOR activation by morphine to NMDA receptor as it relates to acute thermal hyperalgesia. Our experiments show that acute thermal hyperalgesia is blocked in periaqueductal gray with the microOR antagonist CTOP, the NMDA antagonist MK801 and the protein kinase C inhibitor chelerythrine. Therefore, a site of action of systemically administered morphine low dose on acute thermal hyperalgesic response appears to be located at the periaqueductal gray. At this supraspinal site, microOR stimulation by systemically morphine low dose administration leads to an increased phosphorylation of specific subunit of NMDA receptor. Our experiments show that the phosphorylation of subunit 1 of NMDA receptor parallels the acute thermal hyperalgesia suggesting a role for this subunit in morphine-induced hyperalgesia. Protein kinase C appears to be the key element that links microOR activation by morphine administration to mice with the recruitment of the NMDA/glutamatergic system involved in the thermal hyperalgesic response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996026     DOI: 10.1111/j.1471-4159.2007.05117.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Association of mu-opioid and NMDA receptors in the periaqueductal gray: what does it mean for pain control?

Authors:  Susan L Ingram
Journal:  Neuropsychopharmacology       Date:  2012-01       Impact factor: 7.853

2.  Chronic Opioid Therapy Modifies QST Changes After Ketamine Infusion in Chronic Pain Patients.

Authors:  Dermot P Maher; Yi Zhang; Shihab Ahmed; Tina Doshi; Charlene Malarick; Kristin Stabach; Jianren Mao; Lucy Chen
Journal:  J Pain       Date:  2017-08-10       Impact factor: 5.820

3.  Endometriosis Is Associated With a Shift in MU Opioid and NMDA Receptor Expression in the Brain Periaqueductal Gray.

Authors:  Annelyn Torres-Reverón; Karylane Palermo; Anixa Hernández-López; Siomara Hernández; Myrella L Cruz; Kenira J Thompson; Idhaliz Flores; Caroline B Appleyard
Journal:  Reprod Sci       Date:  2016-04-18       Impact factor: 3.060

4.  Supraspinal Gbetagamma-dependent stimulation of PLCbeta originating from G inhibitory protein-mu opioid receptor-coupling is necessary for morphine induced acute hyperalgesia.

Authors:  Enrica Bianchi; Monica Norcini; Alan Smrcka; Carla Ghelardini
Journal:  J Neurochem       Date:  2009-07-27       Impact factor: 5.372

5.  Memantine and dizocilpine interactions with antinociceptive or discriminative stimulus effects of morphine in rats after acute or chronic treatment with morphine.

Authors:  Yukun Chen; Marianne Evola; Alice M Young
Journal:  Psychopharmacology (Berl)       Date:  2012-08-04       Impact factor: 4.530

6.  Neurobiological Aspects of Mindfulness in Pain Autoregulation: Unexpected Results from a Randomized-Controlled Trial and Possible Implications for Meditation Research.

Authors:  Tobias Esch; Jeremy Winkler; Volker Auwärter; Heike Gnann; Roman Huber; Stefan Schmidt
Journal:  Front Hum Neurosci       Date:  2017-01-26       Impact factor: 3.169

7.  Chronic Monoarthritis Pain Accelerates the Processes of Cognitive Impairment and Increases the NMDAR Subunits NR2B in CA3 of Hippocampus from 5-month-old Transgenic APP/PS1 Mice.

Authors:  Wei-Yi Gong; Rong Wang; Yuan Liu; He Jin; Zhi-Wei Zhao; Yu-Lan Wang; Hong-Yan Li; Xu Zhang; Jia-Xiang Ni
Journal:  Front Aging Neurosci       Date:  2017-05-12       Impact factor: 5.750

8.  A role of periaqueductal grey NR2B-containing NMDA receptor in mediating persistent inflammatory pain.

Authors:  Jing Hu; Zhe Wang; Yan-Yan Guo; Xiao-Nan Zhang; Zhao-Hui Xu; Shui-Bing Liu; Hong-Ju Guo; Qi Yang; Fu-Xing Zhang; Xiao-Li Sun; Ming-Gao Zhao
Journal:  Mol Pain       Date:  2009-12-12       Impact factor: 3.395

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.